Revelation Biosciences closes $4M public offering of common stock and warrants

REVELATION BIOSCIENCES, INC.

Gross proceeds ~$4M from sale of 3,640,000 shares (or pre-funded warrants) plus warrants for up to 14,560,000 shares.
Warrants exercise price $1.10/share, exercisable after stockholder approval, expire 5 years from initial exercise date.
Net proceeds to fund Phase 1b study, clinical drug supply manufacture, preclinical work, and general corporate purposes.
Roth Capital Partners acted as sole placement agent; offering closed May 29, 2025.

item 1.01item 3.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.